作者：
Sudha,Sundar [1]
;
Ranjit,Manchanda [2]
;
Charlie,Gourley [3]
;
Angela,George [4]
;
Andrew,Wallace [5]
;
Janos,Balega [6]
;
Sarah,Williams [7]
;
Yvonne,Wallis [8]
;
Richard,Edmondson [9]
;
Shibani,Nicum [10]
;
Jonathan,Frost [11]
;
Ayoma,Attygalle [12]
;
Christina,Fotopoulou [13]
;
Rebecca,Bowen [14]
;
Dani,Bell [12]
;
Ketankumar,Gajjar [15]
;
Bruce,Ramsay [16]
;
Nicholas J,Wood [17]
;
Sadaf,Ghaem-Maghami [18]
;
Tracie,Miles [19]
;
Raji,Ganesan [20]
作者单位：
Gynaecological Oncology, Pan-Birmingham Gynaecological Cancer Centre, Birmingham, UK sudha.sundar@nhs.net.
[1]
Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
[2]
Gynaecological Oncology, Barts Health NHS Trust, Barts Cancer Institute, London, UK.
[3]
University of Edinburgh Cancer Research UK Centre, Edinburgh, UK.
[4]
Royal Marsden Hospital NHS Trust, London, UK.
[5]
Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester, UK.
[6]
Gynaecological Oncology, Pan-Birmingham Gynaecological Cancer Centre, Birmingham, UK.
[7]
University Hospital Birmingham Foundation NHS Trust, Birmingham, UK.
[8]
Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK.
[9]
University of Manchester, Manchester, UK.
[10]
Oxford University Hospitals NHS Trust, Oxford, UK.
[11]
Royal United Hospitals Bath NHS Foundation Trust, Bath, UK.
[12]
Pathology, Royal Marsden NHS Foundation Trust, London, UK.
[13]
Gynaecologic Oncology, Imperial Hospitals NHS trust, London, UK.
[14]
Macmillan Cancer Support, London, UK.
[15]
Nottingham University Hospitals NHS Trust, Nottingham, UK.
[16]
Peterborough City Hospital, Peterborough, Cambridgeshire, UK.
[17]
Obstetrics and Gynaecology, Lancashire Teaching Hospitals NHS Foundation Trust, Preston, UK.
[18]
Imperial College London, London, UK.
[19]
Gynaecological Oncology, Royal United Hospitals, Bath, UK.
[20]
Birmingham Women's and Children's NHS Trust, Birmingham, UK.
[21]
DOI
10.1136/ijgc-2020-002112
PMID
33468564
发布时间
2021-12-22
换一批
换一批
